Latest News
-

Keeping up with HD research just got easier: Introducing the HDBuzz Trial Tracker
⏱️6 min read | Ever wonder when to expect the next update from a clinical trial for Huntington’s disease? The HDBuzz Trial Tracker puts future updates for HD trials on a clear timeline, with deeper explanations in our articles when you want them.
-

Gene silencing takes a targeted step forward
Targeting the mutant Huntington's disease gene for silencing, while leaving the healthy gene untouched
-

Prana Biotech's new trial of PBT2 in Huntington's disease: the lowdown
Prana Biotech's PBT2 trial in Huntington's disease: what we know so far & what copper has to do with the mutant prote
-

Oz Buzz Video: Day 2
The final day of Oz Buzz: the nightly news, interviews and features presentation from the HD World Congress 2011
-

Oz Buzz Video: Day 1
Day 1 of Oz Buzz: the nightly news, interviews and features presentation from the HD World Congress 2011
-

Oz Buzz Updates: Day 3
Day 3 of our coverage of the Huntington's disease World Congress 2011 in Melbourne
-

Oz Buzz Updates: Day 2
Day 2 of our coverage of the Huntington's disease World Congress 2011 in Melbourne
-

Oz Buzz Updates: Day 1
Day 1 of our coverage of the Huntington's disease World Congress 2011 in Melbourne
-

Stand By for Oz Buzz
Follow @HDBuzzFeed and send your questions for the World Congress on Huntington's disease
-

Ten golden rules for reading a scientific news story
Avoid the hype: HDBuzz presents ten 'golden rules' for reading a news story or press release about Huntington's disea
-

Protein-folding drug helps HD mice… for a while
A drug that activates an ancient cellular defense mechanism slows down HD in mice – but why didn’t the benefit last?
HDBuzz Trial Tracker
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
Additional insights from Phase 2 study results and update on plans for Phase 3 trial for votoplam
Previously featured
-
Keeping up with HD research just got easier: Introducing the HDBuzz Trial Tracker
-
Vaccines and Neurodegeneration: Lessons for Huntington’s Disease?
-
UniQure Secures Type A Meeting with FDA: What This Means for AMT-130
-
Putting Huntington’s disease medications to the test: results from the Neuro-HD trial
-
HDBuzz Is Officially Independent: What This Means, and Why It Matters
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
